REQUEST A DEMO
Total
USD $0.00
Search more companies

Regencord Ips S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services | Other Ambulatory Health Care Services
Full name: Regencord Terapia Celular S.A.S. Profile Updated: July 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Regencord Ips S.A.S. is an enterprise based in Colombia. Its main office is in Pereira. The company operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on January 31, 2020. The total number of employees is currently 4 (2026). There was a net sales revenue increase of 58.78% reported in Regencord Ips S.A.S.’s latest financial highlights for 2025. During that time, Regencord Ips S.A.S.’s total assets decreased by 16.88%. The net profit margin of Regencord Ips S.A.S. increased by 1859.63% in 2025.

Headquarters
Cr 13 105 83 Av 30 de Agosto Lc 401
Pereira; Risaralda;

Contact Details: Purchase the Regencord Ips S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Regencord Ips S.A.S. report to view the information.
Financial Auditors:
Purchase the Regencord Ips S.A.S. report to view the information.
Incorporation Date:
January 31, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Regencord Ips S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
58.78%
Total Operating Revenue
58.78%
Operating Profit
-84.35%
Net Profit/Loss for the Period
12826.68%
Total Assets
-16.88%
Total Equity
-74.98%
Operating Profit Margin
-12.65%
Net Profit Margin
1859.63%
Return on Equity (ROE)
15599.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?